- Presentations
- 6
- Markets
- 1
Jadenu is a brand of Deferasirox marketed by Novartis Pharmaceuticals, with 6 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Deferasirox
- Brand owner
- Novartis Pharmaceuticals
- Registered in
- United States
- Strengths and forms
- 180 mg granules, 360 mg granules, 90 mg granules, 180 mg tablet, 360 mg tablet, 90 mg tablet
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Jadenu 180 mg granulesOral | Novartis Pharmaceuticals | US FDA | Available on request |
| Jadenu 360 mg granulesOral | Novartis Pharmaceuticals | US FDA | Available on request |
| Jadenu 90 mg granulesOral | Novartis Pharmaceuticals | US FDA | Available on request |
| Jadenu 180 mg tabletOral | Novartis Pharmaceuticals | US FDA | Available on request |
| Jadenu 360 mg tabletOral | Novartis Pharmaceuticals | US FDA | Available on request |
| Jadenu 90 mg tabletOral | Novartis Pharmaceuticals | US FDA | Available on request |
Equivalent brands
Other brands of Deferasirox.
Brand names and trademarks belong to their owners and are used only to identify products.
Request Jadenu
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.